Published in Mol Pain on April 26, 2011
Pain without nociceptors? Nav1.7-independent pain mechanisms. Cell Rep (2014) 1.50
Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci (2017) 1.38
Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience (2011) 1.16
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A (2013) 1.08
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways. Pain (2013) 0.98
G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition. Nat Neurosci (2015) 0.94
TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways. J Neurosci (2013) 0.91
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity. PLoS One (2015) 0.91
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse. PLoS One (2013) 0.86
A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy. PLoS One (2013) 0.85
Anticancer activity of methyl-substituted oxaliplatin analogs. Mol Pharmacol (2012) 0.84
Serotonergic mechanism of the relieving effect of bee venom acupuncture on oxaliplatin-induced neuropathic cold allodynia in rats. BMC Complement Altern Med (2014) 0.81
Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin. Neuro Oncol (2014) 0.79
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. Eur J Cancer Care (Engl) (2015) 0.78
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy. Clin Cancer Res (2016) 0.78
Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice. Br J Pharmacol (2016) 0.78
Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics. Curr Opin Support Palliat Care (2016) 0.77
Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats. Sci Rep (2015) 0.77
Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation. PLoS One (2015) 0.77
Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX. Chemother Res Pract (2013) 0.76
Effects of Oxaliplatin Treatment on the Enteric Glial Cells and Neurons in the Mouse Ileum. J Histochem Cytochem (2016) 0.76
Celecoxib alleviates oxaliplatin-induced hyperalgesia through inhibition of spinal ERK1/2 signaling. J Toxicol Pathol (2016) 0.75
New tools for the quantitative assessment of prodrug delivery and neurotoxicity. Neurotoxicology (2015) 0.75
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24
A TRP channel that senses cold stimuli and menthol. Cell (2002) 8.66
Evidence for a central component of post-injury pain hypersensitivity. Nature (1984) 4.41
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol (2003) 4.34
MAP kinase and pain. Brain Res Rev (2008) 3.75
Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol (2005) 3.72
Chemotherapy-induced neuropathy. J Peripher Nerv Syst (2008) 2.97
Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res (1991) 2.81
Mechanisms of disease: neuropathic pain--a clinical perspective. Nat Clin Pract Neurol (2006) 2.44
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol (2002) 2.15
Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol (1998) 2.11
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol (2002) 2.11
Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther (2009) 2.10
Oxaliplatin-safety profile: neurotoxicity. Semin Oncol (2003) 1.94
The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol (2000) 1.91
Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve (2004) 1.91
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain (2009) 1.77
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol (1996) 1.76
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol (2001) 1.73
An improved method for assessing mechanical allodynia in the rat. Physiol Behav (1999) 1.68
Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol (2006) 1.67
Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol Dis (2005) 1.65
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol (1999) 1.64
Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol (2006) 1.58
BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res Mol Brain Res (1998) 1.53
Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain (2008) 1.52
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain (2009) 1.50
Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A (1999) 1.50
Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci (2003) 1.40
Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim Biophys Acta (2000) 1.40
Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol (1995) 1.39
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli. Mol Pain (2009) 1.37
Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve (2005) 1.37
Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol (2009) 1.37
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol (1998) 1.34
Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer (2001) 1.33
Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol (1998) 1.31
Switch to Ca2+-permeable AMPA and reduced NR2B NMDA receptor-mediated neurotransmission at dorsal horn nociceptive synapses during inflammatory pain in the rat. J Physiol (2007) 1.29
Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. J Pain (2009) 1.28
Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res (2008) 1.25
Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain (2003) 1.24
Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics (2009) 1.24
Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol (2000) 1.23
Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci Lett (2009) 1.21
Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. J Physiol (2009) 1.19
Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. Toxicol Sci (1998) 1.17
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer (2005) 1.16
Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol Dis (2002) 1.16
Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol (1992) 1.15
An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol (1993) 1.12
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial. J Clin Oncol (2002) 1.09
Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. Toxicology (2007) 1.08
Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain (2006) 1.08
Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Exp Neurol (2001) 1.07
Responses of spinothalamic tract neurons to mechanical and thermal stimuli in an experimental model of peripheral neuropathy in primates. J Neurophysiol (1992) 1.01
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer Chemother Pharmacol (2005) 1.01
Increases in the concentration of brain derived neurotrophic factor in the lumbar spinal dorsal horn are associated with pain behavior following chronic constriction injury in rats. Neurosci Lett (2002) 1.00
Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer (2001) 1.00
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies. Exp Neurol (2010) 0.99
Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Acta Oncol (2007) 0.99
Expression of neurotrophin mRNAs in the dorsal root ganglion after spinal nerve injury. Brain Res Mol Brain Res (1999) 0.98
Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy. Brain Res (2008) 0.98
Expression of brain-derived neurotrophic factor in rat dorsal root ganglia, spinal cord and gracile nuclei in experimental models of neuropathic pain. Neuroscience (2001) 0.98
Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology (2009) 0.97
Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit. Biol Pharm Bull (2009) 0.95
Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. Anticancer Res (2005) 0.95
Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons. Mol Pain (2010) 0.91
Neuron type-specific effects of brain-derived neurotrophic factor in rat superficial dorsal horn and their relevance to 'central sensitization'. J Physiol (2007) 0.91
Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue. Mol Pain (2009) 0.91
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin. Cancer Chemother Pharmacol (2007) 0.90
Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice. Brain Res (2003) 0.90
Effects of repeated administration of low doses of cisplatin on the rat nervous system. Int J Tissue React (1991) 0.90
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat. Anticancer Res (2003) 0.85
Increased WDR spontaneous activity and receptive field size in rats following a neuropathic or inflammatory injury: implications for mechanical sensitivity. Neurosci Lett (2004) 0.85
Influence of malnutrition on developing rat peripheral nerves. Exp Neurol (1988) 0.82
First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study. Bull Cancer (2009) 0.81
Role of input from saphenous afferents in altered spinal processing of noxious signal that follows sciatic nerve constriction in rats. Neurosci Lett (1997) 0.80
Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity. Br J Cancer (2003) 0.80
Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer. Anticancer Drugs (2006) 0.79
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat. Cancer Chemother Pharmacol (2002) 0.78
[Oxaliplatin and ovarian cancer]. Bull Cancer (2006) 0.78
Long-term effects of brain-derived neurotrophic factor on the frequency of inhibitory synaptic events in the rat superficial dorsal horn. Neuroscience (2009) 0.78
Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma (2007) 4.17
The effect of trauma center designation and trauma volume on outcome in specific severe injuries. Ann Surg (2005) 2.49
High success with nonoperative management of blunt hepatic trauma: the liver is a sturdy organ. Arch Surg (2003) 2.09
Advanced trauma life support, 8th edition, the evidence for change. J Trauma (2008) 2.07
Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med (2005) 1.97
Tissue oxygen saturation predicts the development of organ dysfunction during traumatic shock resuscitation. J Trauma (2007) 1.97
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol (2012) 1.95
Trauma fatalities: time and location of hospital deaths. J Am Coll Surg (2004) 1.87
Relationship between American College of Surgeons trauma center designation and mortality in patients with severe trauma (injury severity score > 15). J Am Coll Surg (2005) 1.87
Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma (2004) 1.84
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol (2011) 1.82
Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65
Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg (2010) 1.64
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry (2013) 1.55
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension (2011) 1.54
Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal (2012) 1.54
Preventable or potentially preventable mortality at a mature trauma center. J Trauma (2007) 1.54
Selective nonoperative management of penetrating abdominal solid organ injuries. Ann Surg (2006) 1.53
Effects of hemodynamics on global and regional lung perfusion: a quantitative lung perfusion study by magnetic resonance imaging. Circ Cardiovasc Imaging (2012) 1.48
The impact of obesity on the outcomes of 1,153 critically injured blunt trauma patients. J Trauma (2005) 1.46
Hepatic apoptosis after hemorrhagic shock in rats can be reduced through modifications of conventional Ringer's solution. J Am Coll Surg (2005) 1.46
Profound hypothermic cardiopulmonary bypass facilitates survival without a high complication rate in a swine model of complex vascular, splenic, and colon injuries. J Am Coll Surg (2007) 1.45
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res (2003) 1.45
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol (2012) 1.44
Postdischarge complications after penetrating cardiac injury: a survivable injury with a high postdischarge complication rate. Arch Surg (2011) 1.43
Blunt cardiac rupture: a 5-year NTDB analysis. J Trauma (2009) 1.42
Pediatric all-terrain vehicle trauma: the epidemic continues unabated. Pediatr Emerg Care (2012) 1.41
The effect of a protocol of aggressive donor management: Implications for the national organ donor shortage. J Trauma (2006) 1.41
Trauma deaths in a mature urban trauma system: is "trimodal" distribution a valid concept? J Am Coll Surg (2005) 1.40
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst (2005) 1.37
Measurable outcomes of quality improvement in the trauma intensive care unit: the impact of a daily quality rounding checklist. J Trauma (2008) 1.35
Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg (2010) 1.35
Mortality prediction of head Abbreviated Injury Score and Glasgow Coma Scale: analysis of 7,764 head injuries. J Am Coll Surg (2004) 1.33
Pedestrians injured by automobiles: relationship of age to injury type and severity. J Am Coll Surg (2004) 1.30
Complications and death at the start of the new academic year: is there a July phenomenon? J Trauma (2010) 1.27
Massive transfusion in trauma patients: tissue hemoglobin oxygen saturation predicts poor outcome. J Trauma (2008) 1.26
Early hypothermia in severely injured trauma patients is a significant risk factor for multiple organ dysfunction syndrome but not mortality. Ann Surg (2009) 1.25
A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin. J Cell Biol (2006) 1.24
The increasing use of chest computed tomography for trauma: is it being overutilized? J Trauma (2007) 1.24
Does the rate of rewarming from profound hypothermic arrest influence the outcome in a swine model of lethal hemorrhage? J Trauma (2006) 1.23
New developments in fluid resuscitation. Surg Clin North Am (2007) 1.23
Impact of plasma transfusion in massively transfused trauma patients. J Trauma (2009) 1.23
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. Cancer Res (2011) 1.21
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res (2006) 1.15
Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? World J Surg (2014) 1.14
Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J Neurosci (2009) 1.13
Adolescent assault injury: risk and protective factors and locations of contact for intervention. Pediatrics (2003) 1.13
Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg (2012) 1.11
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. Eur J Cancer (2005) 1.11
Does routine serial computed tomography of the head influence management of traumatic brain injury? A prospective evaluation. J Trauma (2004) 1.11
Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. Resuscitation (2004) 1.10
Obesity and traumatic brain injury. J Trauma (2006) 1.10
Clinical practice guideline: penetrating zone II neck trauma. J Trauma (2008) 1.09
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A (2013) 1.08
The impact of obesity on severely injured children and adolescents. J Pediatr Surg (2006) 1.08
Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res (2011) 1.08
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer (2012) 1.08
Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev (2011) 1.07
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine (2012) 1.03
Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg (2012) 1.02
Management and hospital outcomes of blunt renal artery injuries: analysis of 517 patients from the National Trauma Data Bank. J Am Coll Surg (2006) 1.01
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat. Neurotox Res (2009) 1.01
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats. J Pain Res (2012) 1.00
High-level falls: type and severity of injuries and survival outcome according to age. J Trauma (2005) 1.00
Hemodynamically "stable" patients with peritonitis after penetrating abdominal trauma: identifying those who are bleeding. Arch Surg (2005) 1.00
Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. Surgery (2007) 0.99
Predictors of mortality in geriatric trauma patients: a systematic review and meta-analysis. J Trauma Acute Care Surg (2014) 0.99
Beta-blockers in isolated blunt head injury. J Am Coll Surg (2007) 0.98
Indications for routine repeat head computed tomography (CT) stratified by severity of traumatic brain injury. J Trauma (2007) 0.98
The decreasing incidence of late posttraumatic acute respiratory distress syndrome: the potential role of lung protective ventilation and conservative transfusion practice. J Trauma (2007) 0.98
Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in Swine. J Trauma (2004) 0.98
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases. Neurol Sci (2009) 0.98
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system. Curr Med Chem (2009) 0.98
Is there a role for aggressive use of fresh frozen plasma in massive transfusion of civilian trauma patients? Am J Surg (2008) 0.98
Pedestrians injured by automobiles: risk factors for cervical spine injuries. J Am Coll Surg (2007) 0.98
Troponin increases in the critically injured patient: mechanical trauma or physiologic stress? J Trauma (2005) 0.97
Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology (2009) 0.97
Hepatic and pulmonary apoptosis after hemorrhagic shock in swine can be reduced through modifications of conventional Ringer's solution. J Trauma (2006) 0.97
Integrated compensatory network is activated in the absence of NCC phosphorylation. J Clin Invest (2015) 0.96
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale. J Peripher Nerv Syst (2011) 0.95
Practice management guidelines for the screening of thoracolumbar spine fracture. J Trauma (2007) 0.95
Improving consent rates for organ donation: the effect of an inhouse coordinator program. J Trauma (2007) 0.95
Significance of troponin elevation after severe traumatic brain injury. J Trauma (2008) 0.95
Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Surgery (2006) 0.95
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats. Eur J Pain (2009) 0.95
Relationship of phasic left atrial volume and emptying function to left ventricular filling pressure: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2013) 0.94
Neuroactive steroids and peripheral neuropathy. Brain Res Rev (2007) 0.94
Enterocutaneous fistula complicating trauma laparotomy: a major resource burden. Am Surg (2009) 0.94
Near-hanging injuries: a 10-year experience. Injury (2006) 0.93
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. Am J Hematol (2014) 0.93
Outcome and prognostic factors in head injuries with an admission Glasgow Coma Scale score of 3. Arch Surg (2004) 0.93
Tactical surgical intervention with temporary shunting of peripheral vascular trauma sustained during Operation Iraqi Freedom: one unit's experience. J Trauma (2006) 0.93
Impact of the 80-hour workweek on patient care at a level I trauma center. Arch Surg (2007) 0.93
Peripheral neurotoxicity of platinum-based chemotherapy. Nat Rev Cancer (2008) 0.93
Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One (2011) 0.92
Shock index predicts mortality in geriatric trauma patients: an analysis of the National Trauma Data Bank. J Trauma Acute Care Surg (2014) 0.92
A critical analysis of secondary overtriage to a Level I trauma center. J Trauma Acute Care Surg (2014) 0.91
TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways. J Neurosci (2013) 0.91
A comparison of video laryngoscopy to direct laryngoscopy for the emergency intubation of trauma patients. World J Surg (2015) 0.91